Public health surveillance

Last updated

Public health surveillance (also epidemiological surveillance, clinical surveillance or syndromic surveillance) is, according to the World Health Organization (WHO), "the continuous, systematic collection, analysis and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice." [1] Public health surveillance may be used to track emerging health-related issues at an early stage and find active solutions in a timely manner. [1] Surveillance systems are generally called upon to provide information regarding when and where health problems are occurring and who is affected. [2]

Contents

Public health surveillance systems can be passive or active. A passive surveillance system consists of the regular, ongoing reporting of diseases and conditions by all health facilities in a given territory. An active surveillance system is one where health facilities are visited and health care providers and medical records are reviewed in order to identify a specific disease or condition. [3] Passive surveillance systems are less time-consuming and less expensive to run but risk under-reporting of some diseases. Active surveillance systems are most appropriate for epidemics or where a disease has been targeted for elimination. [3]

Techniques of public health surveillance have been used in particular to study infectious diseases. Many large institutions, such as the WHO and the Centers for Disease Control and Prevention (CDC), have created databases and modern computer systems (public health informatics) that can track and monitor emerging outbreaks of illnesses such as influenza, SARS, HIV, and even bioterrorism, such as the 2001 anthrax attacks in the United States.[ citation needed ]

Many regions and countries have their own cancer registry, which is monitors the incidence of cancers to determine the prevalence and possible causes of these illnesses. [4]

Other illnesses such as one-time events like stroke and chronic conditions such as diabetes, as well as social problems such as domestic violence, are increasingly being integrated into epidemiologic databases called disease registries. A cost-benefit analysis is conducted on these registries to determine governmental funding for research and prevention.

Systems that can automate the process of identifying adverse drug events, are currently being used, and are being compared to traditional written reports of such events. [5] These systems intersect with the field of medical informatics, and are rapidly becoming adopted by hospitals and endorsed by institutions that oversee healthcare providers (such as JCAHO in the United States). Issues in regard to healthcare improvement are evolving around the surveillance of medication errors within institutions. [6]

Syndromic surveillance

Syndromic surveillance is the analysis of medical data to detect or anticipate disease outbreaks. According to a CDC definition, "the term 'syndromic surveillance' applies to surveillance using health-related data that precede diagnosis and signal a sufficient probability of a case or an outbreak to warrant further public health response. Though historically syndromic surveillance has been utilized to target investigation of potential cases, its utility for detecting outbreaks associated with bioterrorism is increasingly being explored by public health officials." [7]

The first indications of disease outbreak or bioterrorist attack may not be the definitive diagnosis of a physician or a lab. [8]

Using a normal influenza outbreak as an example, once the outbreak begins to affect the population, some people may call in sick for work/school, others may visit their drug store and purchase medicine over the counter, others will visit their doctor's office and other's may have symptoms severe enough that they call the emergency telephone number or go to an emergency department.[ citation needed ]

Syndromic surveillance systems monitor data from school absenteeism logs, emergency call systems, hospitals' over-the-counter drug sale records, Internet searches, and other data sources to detect unusual patterns. When a spike in activity is seen in any of the monitored systems disease epidemiologists and public health professionals are alerted that there may be an issue. [9]

An early awareness and response to a bioterrorist attack could save many lives and potentially stop or slow the spread of the outbreak. The most effective syndromic surveillance systems automatically monitor these systems in real-time, do not require individuals to enter separate information (secondary data entry), include advanced analytical tools, aggregate data from multiple systems, across geo-political boundaries and include an automated alerting process. [10]

A syndromic surveillance system based on search queries was first proposed by Gunther Eysenbach, who began work on such a system in 2004. [11] Inspired by these early, encouraging experiences, Google launched Google Flu Trends [12] in 2008. More flu-related searches are taken to indicate higher flu activity. The results, which were published in Nature, closely matched CDC data, and led it by 1–2 weeks. [13] However, it has been shown that the original approach behind Google Flu Trends had various modelling deficiencies leading to significant errors in its estimates. [14] More recently, a series of more advanced linear and nonlinear approaches to influenza modeling from Google search queries have been proposed. [15] Extending Google's work researchers from the Intelligent Systems Laboratory (University of Bristol, UK) created Flu Detector; [16] an online tool which based on Information Retrieval and Statistical Analysis methods uses the content of Twitter to nowcast flu rates in the UK. [17]

Digital methods

Digital surveillance of public health largely relies on a number of methods. The most important ones being the use of search-based trends on sites like Google and Wikipedia, social media posts on platforms like Facebook and Twitter, and participatory surveillance websites such as Flu Near You and Influenzanet. However the range of potential data sources suitable for disease surveillance has increased as different areas have become digitized; today school attendance records, hospital emergency admissions data and even sales data, can be used for syndromic surveillance purposes. Search trends provide indirect data on public health, while the latter two methods provide direct data. [18]

Search aggregates

Search aggregates have been most frequently used to track and model influenza. A popular example is Google Flu Trends, [19] which was first released in 2008. [18] Wikipedia has also been used, though it is potentially prone to "noise", as it is a popular source of health information whether a user is ill or not. [20] During the COVID-19 pandemic a new methodology has been developed to model COVID-19 prevalence based on web search activity. [21] This methodology has also been used by Public Health England in the United Kingdom as one of their syndromic surveillance endpoints.[ citation needed ]

Social media

Examples of social media public health surveillance include HealthTweets, which gathers data from Twitter. [20] Twitter data is considered highly useful for public health research, as its data policies allow public access to 1% samples of raw tweets. Tweets can also be geolocated, which can be used to model the spread of contagious disease. It is the most used social media platform for public health surveillance. [18] During the COVID-19 pandemic, Facebook used aggregated, anonymized data collected from its platforms to provide human movement information to disease models. It also offered users a chance to participate in a disease symptom survey through Carnegie Mellon University. [22]

Surveillance sites

Flu Near You and Influenzanet are two examples of crowd-sourced digital surveillance systems. Both sites recruit users to participate in surveys about influenza symptoms. Influenzanet was established in 2009, and operates in ten countries in Europe. Its predecessor was Grote Griepmeting, which was a Dutch/Belgian platform launched in 2003 and 2004. Flu Near You is used in the US. Another example of a surveillance sites is Dengue na Web, used to survey for dengue fever in Bahia, Brazil. [18]

Laboratory-based surveillance

Some conditions, especially chronic diseases such as diabetes mellitus, are supposed to be routinely managed with frequent laboratory measurements. Since many laboratory results, at least in Europe and the US, are automatically processed by computerized laboratory information systems, the results are relatively easy to inexpensively collate in special purpose databases or disease registries. Unlike most syndromic surveillance systems, in which each record is assumed to be independent of the others, laboratory data in chronic conditions can be theoretically linked together at the individual patient level. If patient identifiers can be matched, a chronological record of each patient's laboratory results can be analyzed as well as aggregated to the population level.[ citation needed ]

Laboratory registries allow for the analysis of the incidence and prevalence of the target condition as well as trends in the level of control. For instance, an NIH-funded program called the Vermedx Diabetes Information System [23] maintained a registry of laboratory values of diabetic adults in Vermont and northern New York State in the US with several years of laboratory results on thousands of patients. [24] The data included measures of blood sugar control (glycated hemoglobin A1c), cholesterol, and kidney function (serum creatinine and urine protein), and were used to monitor the quality of care at the patient, practice, and population levels. Since the data contained each patient's name and address, the system was also used to communicate directly with patients when the laboratory data indicated the need for attention. Out of control test results generated a letter to the patient suggesting they take action with their medical provider. Tests that were overdue generated reminders to have testing performed. The system also generated reminders and alerts with guideline-based advice for the practice as well as a periodic roster of each provider's patients and a report card summarizing the health status of the population. Clinical and economic evaluations of the system, including a large randomized clinical trial, demonstrated improvements in adherence to practice guidelines and reductions in the need for emergency department and hospital services as well as total costs per patient. [25] [26] [27] The system has been commercialized and distributed to physicians, insurers, employers and others responsible for the care of chronically ill patients. It is now being expanded to other conditions such as chronic kidney disease.[ citation needed ]

A similar system, The New York City A1C Registry, [28] is in used to monitor the estimated 600,000 diabetic patients in New York City, although unlike the Vermont Diabetes Information System, there are no provisions for patients to have their data excluded from the NYC database. The NYC Department of Health and Mental Hygiene has linked additional patient services to the registry such as health information and improved access to health care services. As of early 2012, the registry contains over 10 million test results on 3.6 million individuals. Although intended to improve health outcomes and reduce the incidence of the complications of diabetes, [29] a formal evaluation has not yet been done.

In May 2008, the City Council of San Antonio, Texas approved the deployment of an A1C registry for Bexar County. Authorized by the Texas legislature and the state Health Department, the San Antonio Metropolitan Health District [30] implemented the registry which drew results from all the major clinical laboratories in San Antonio. The program was discontinued in 2010 due to lack of funds.[ citation needed ]

Laboratory surveillance differs from population-wide surveillance because it can only monitor patients who are already receiving medical treatment and therefore having lab tests done. For this reason, it does not identify patients who have never been tested. Therefore, it is more suitable for quality management and care improvement than for epidemiological monitoring of an entire population or catchment area.[ citation needed ]

See also

Related Research Articles

<i>Influenza A virus</i> Species of virus

Influenza A virus (IAV) is the only species of the genus Alphainfluenzavirus of the virus family Orthomyxoviridae. It is a pathogen with strains that infect birds and some mammals, as well as causing seasonal flu in humans. Mammals in which different strains of IAV circulate with sustained transmission are bats, pigs, horses and dogs; other mammals can occasionally become infected.

<span class="mw-page-title-main">Avian influenza</span> Influenza caused by viruses adapted to birds

Avian influenza, also known as avian flu or bird flu, is a disease caused by the influenza A virus, which primarily affects birds but can sometimes affect mammals including humans. Wild aquatic birds are the primary host of the influenza A virus, which is enzootic in many bird populations.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, colloquially known as flu shots or the flu jab, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945.

Glycated hemoglobin is a form of hemoglobin (Hb) that is chemically linked to a sugar.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

<span class="mw-page-title-main">Flu season</span> Recurring periods of influenza

Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza (flu). The season occurs during the cold half of the year in each hemisphere. It takes approximately two days to show symptoms. Influenza activity can sometimes be predicted and even tracked geographically. While the beginning of major flu activity in each season varies by location, in any specific location these minor epidemics usually take about three weeks to reach its pinnacle, and another three weeks to significantly diminish.

<span class="mw-page-title-main">Influenza A virus subtype H1N1</span> Subtype of Influenza A virus

Influenza A virus subtype H1N1 (A/H1N1) is a subtype of influenza A virus (IAV). Some human-adapted strains of H1N1 are endemic in humans and are one cause of seasonal influenza (flu). Other strains of H1N1 are endemic in pigs and in birds. Subtypes of IAV are defined by the combination of the antigenic H and N proteins in the viral envelope; for example, "H1N1" designates an IAV subtype that has a type-1 hemagglutinin (H) protein and a type-1 neuraminidase (N) protein.

<span class="mw-page-title-main">Disease surveillance</span> Monitoring spread of disease to establish patterns of progression

Disease surveillance is an epidemiological practice by which the spread of disease is monitored in order to establish patterns of progression. The main role of disease surveillance is to predict, observe, and minimize the harm caused by outbreak, epidemic, and pandemic situations, as well as increase knowledge about which factors contribute to such circumstances. A key part of modern disease surveillance is the practice of disease case reporting.

<span class="mw-page-title-main">Influenza-like illness</span> Medical diagnosis

Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, nausea, and sneezing typically in connection with a sudden onset of illness. In most cases, the symptoms are caused by cytokines released by immune system activation, and are thus relatively non-specific.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus. The first identified human case was in La Gloria, Mexico, a rural town in Veracruz. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

<span class="mw-page-title-main">Pandemic H1N1/09 virus</span> Virus responsible for the 2009 swine flu pandemic

The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media due to the prevailing belief that it originated in pigs. The virus is believed to have originated around September 2008 in central Mexico.

Infoveillance is a type of syndromic surveillance that specifically utilizes information found online. The term, along with the term infodemiology, was coined by Gunther Eysenbach to describe research that uses online information to gather information about human behavior.

<span class="mw-page-title-main">Google Flu Trends</span> Former web service operated by Google

Google Flu Trends (GFT) was a web service operated by Google. It provided estimates of influenza activity for more than 25 countries. By aggregating Google Search queries, it attempted to make accurate predictions about flu activity. This project was first launched in 2008 by Google.org to help predict outbreaks of flu.

Infodemiology was defined by Gunther Eysenbach in the early 2000s as information epidemiology. It is an area of science research focused on scanning the internet for user-contributed health-related content, with the ultimate goal of improving public health. Later, it is also defined as the science of mitigating public health problems resulting from an infodemic.

Data philanthropy refers to private sector companies sharing data they collected for the public good, often to help address social or environmental challenges for public benefit. The concept was popularized through its introduction by the United Nations Global Pulse initiative in 2011 to leverage corporate data assets for humanitarian, academic, and societal causes. For instance, anonymized mobile data has been used to track disease outbreaks. In contrast, corporate data on consumer behavior may be shared with researchers to study public health and economic trends.

Participatory surveillance is community-based monitoring of other individuals. This term can be applied to both digital media studies and ecological field studies. In the realm of media studies, it refers to how users surveil each other using the internet. Either through the use of social media, search engines, and other web-based methods of tracking, an individual has the power to find information both freely or non freely given about the individual being searched. Issues of privacy emerge within this sphere of participatory surveillance, predominantly focused on how much information is available on the web that an individual does not consent to. More so, disease outbreak researchers can study social-media based patterns to decrease the time it takes to detect an outbreak, an emerging field of study called infodemiology. Within the realm of ecological fieldwork, participatory surveillance is used as an overarching term for the method in which indigenous and rural communities are used to gain greater accessibility to causes of disease outbreak. By using these communities, disease outbreak can be spotted earlier than through traditional means or healthcare institutions.

<span class="mw-page-title-main">Caitlin Rivers</span> American epidemiologist

Caitlin M. Rivers is an American epidemiologist who as Senior Scholar at the Johns Hopkins Center for Health Security and assistant professor at the Johns Hopkins Bloomberg School of Public Health, specializing on improving epidemic preparedness. Rivers is currently working on the American response to the COVID-19 pandemic with a focus on the incorporation of infectious disease modeling and forecasting into public health decision making.

<span class="mw-page-title-main">1957–1958 influenza pandemic</span> Pandemic of influenza virus (H2N2)

The 1957–1958 Asian flu pandemic was a global pandemic of influenza A virus subtype H2N2 that originated in Guizhou in Southern China. The number of excess deaths caused by the pandemic is estimated to be 1–4 million around the world, making it one of the deadliest pandemics in history. A decade later, a reassorted viral strain H3N2 further caused the Hong Kong flu pandemic (1968–1969).

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

The Global Influenza Surveillance and Response System (GISRS) is a global network of laboratories that has the purpose to monitor the spread of influenza with the aim to provide the World Health Organization with influenza control information. It was established in 1952 to conduct global influenza surveillance and to inform vaccine development. GISRS is coordinated by WHO and endorsed by national governments. Several millions of respiratory specimens are tested by GISRS annually to monitor the spread and evolution of influenza viruses through a network of laboratories in 127 countries representing 91% of the world's population. As well as human viruses, GISRS monitors avian and other potentially zoonotic influenza viruses. GISRS operates FluNet, an online tool used for virological surveillance of influenza.

References

  1. 1 2 Public health surveillance, World Health Organization (accessed January 14, 2016).
  2. ↑ Caves RW (2004). Encyclopedia of the City . Routledge. pp.  548. ISBN   9780415252256.
  3. 1 2 World Health Organization. "Surveillance for Vaccine Preventable Diseases". World Health Organization: Immunization, Vaccines and Biologicals. Archived from the original on April 1, 2014. Retrieved 19 October 2016.
  4. ↑ White, Mary C.; Babcock, Frances; Hayes, Nikki S.; Mariotto, Angela B.; Wong, Faye L.; Kohler, Betsy A.; Weir, Hannah K. (2017-12-15). "The History and Use of Cancer Registry Data by Public Health Cancer Control Programs in the United States". Cancer. 123 (Suppl 24): 4969–4976. doi:10.1002/cncr.30905. ISSN   0008-543X. PMC   5846186 . PMID   29205307.
  5. ↑ Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG (Jul–Aug 2006). "Automated surveillance for adverse drug events at a community hospital and an academic medical center". Journal of the American Medical Informatics Association. 13 (4): 372–7. doi:10.1197/jamia.M2069. PMC   1513675 . PMID   16622159.
  6. ↑ disa.mil [ dead link ] PDF
  7. ↑ "webcitation.org". webcitation.org. Archived from the original on June 24, 2003. Retrieved 2014-04-18.{{cite web}}: CS1 maint: unfit URL (link)
  8. ↑ Henning KJ (September 2004). "What is syndromic surveillance?". MMWR Supplements. 53: 5–11. PMID   15714620.
  9. ↑ Walker, Mark (2023). Digital Epidemiology: An introduction to disease surveillance using digital data. Sheffield,UK: Sicklebrook publishing. ISBN   978-1470920364.
  10. ↑ "Syndromic Surveillance: an Applied Approach to Outbreak Detection". United States Centers for Disease Control and Prevention. 13 January 2006. Archived from the original on 20 January 2007.
  11. ↑ Eysenbach G (2006). "Infodemiology: tracking flu-related searches on the web for syndromic surveillance". AMIA ... Annual Symposium Proceedings. AMIA Symposium. 2006: 244–8. PMC   1839505 . PMID   17238340.
  12. ↑ "Google Flu Trends". Google.org. Retrieved 2014-04-18.
  13. ↑ Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L (February 2009). "Detecting influenza epidemics using search engine query data". Nature. 457 (7232): 1012–4. Bibcode:2009Natur.457.1012G. doi: 10.1038/nature07634 . PMID   19020500. S2CID   125775.
  14. ↑ Lazer D, Kennedy R, King G, Vespignani A (2014). "The Parable of Google Flu: Traps in Big Data Analysis". Science. 343 (6176): 1203–1205. Bibcode:2014Sci...343.1203L. doi:10.1126/science.1248506. PMID   24626916. S2CID   206553739.
  15. ↑ Lampos V, Miller AC, Crossan S, Stefansen C (August 2015). "Advances in nowcasting influenza-like illness rates using search query logs". Scientific Reports. 5 (12760): 12760. Bibcode:2015NatSR...512760L. doi:10.1038/srep12760. PMC   4522652 . PMID   26234783.
  16. ↑ "Flu Detector – Tracking Epidemics on Twitter". GeoPatterns.enm.bris.ac.uk. Retrieved 2014-04-18.
  17. ↑ Lampos V, De Bie T, Cristianini N (2010). Flu Detector – Tracking Epidemics on Twitter. ECML PKDD. pp. 599–602. doi: 10.1007/978-3-642-15939-8_42 .
  18. 1 2 3 4 Aiello AE, Renson A, Zivich PN (April 2020). "Social Media- and Internet-Based Disease Surveillance for Public Health". Annual Review of Public Health. 41: 101–118. doi: 10.1146/annurev-publhealth-040119-094402 . PMC   7959655 . PMID   31905322.
  19. ↑ Brownstein, John S.; Freifeld, Clark C.; Madoff, Lawrence C. (2009-05-21). "Digital Disease Detection — Harnessing the Web for Public Health Surveillance". New England Journal of Medicine. 360 (21): 2153–2157. doi:10.1056/NEJMp0900702. ISSN   0028-4793. PMC   2917042 . PMID   19423867.
  20. 1 2 Sharpe JD, Hopkins RS, Cook RL, Striley CW (October 2016). "Evaluating Google, Twitter, and Wikipedia as Tools for Influenza Surveillance Using Bayesian Change Point Analysis: A Comparative Analysis". JMIR Public Health and Surveillance. 2 (2): e161. doi: 10.2196/publichealth.5901 . PMC   5095368 . PMID   27765731.
  21. ↑ Lampos V, Majumder MS, Yom-Tov E, et al. (2021). "Tracking COVID-19 using online search". npj Digital Medicine. 4 (17): 17. arXiv: 2003.08086 . doi: 10.1038/s41746-021-00384-w . PMC   7870878 . PMID   33558607.
  22. ↑ Newton C (6 April 2020). "Facebook begins sharing more location data with COVID-19 researchers and asks users to self-report symptoms". The Verge. Retrieved 2 September 2020.
  23. ↑ "Vermedx Diabetes Information System". vermedx.com. Archived from the original on 2011-02-02. Retrieved 2014-04-18.
  24. ↑ MacLean CD, Littenberg B, Gagnon M (April 2006). "Diabetes decision support: initial experience with the Vermont diabetes information system". American Journal of Public Health. 96 (4). Ajph.org: 593–5. doi:10.2105/AJPH.2005.065391. PMC   1470550 . PMID   16507723.
  25. ↑ Littenberg B, MacLean CD, Zygarowski K, Drapola BH, Duncan JA, Frank CR (March 2009). "The Vermedx Diabetes Information System reduces healthcare utilization". The American Journal of Managed Care. 15 (3): 166–70. PMID   19298097.
  26. ↑ Maclean CD, Gagnon M, Callas P, Littenberg B (December 2009). "The Vermont diabetes information system: a cluster randomized trial of a population based decision support system". Journal of General Internal Medicine. 24 (12): 1303–10. doi:10.1007/s11606-009-1147-x. PMC   2787948 . PMID   19862578.
  27. ↑ Khan S, Maclean CD, Littenberg B (July 2010). "The effect of the Vermont Diabetes Information System on inpatient and emergency room use: results from a randomized trial". Health Outcomes Research in Medicine. 1 (1): e61–e66. doi:10.1016/j.ehrm.2010.03.002. PMC   2958673 . PMID   20975923.
  28. ↑ "Diabetes Prevention and Control". The New York City A1C Registry. The City of New York. Archived from the original on June 9, 2007.
  29. ↑ Frieden TR (September 2008). "New York City's diabetes reporting system helps patients and physicians". American Journal of Public Health. 98 (9). Ajph.aphapublications.org: 1543–4, author reply 1544. doi:10.2105/AJPH.2008.142026. PMC   2509589 . PMID   18633070.
  30. ↑ "Metropolitan Health District". Sanantonio.gov. Retrieved 2014-04-18.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.